Entasis Therapeutics Holdings Inc. SC 13D and SC 13D/A reports

Location
35 Gatehouse Drive, Waltham, MA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
7/30/2024, 05:08 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report SC 13D/A Jul 11, 2022
SC 13D/A Report SC 13D/A May 24, 2022
SC 13D/A Report SC 13D/A Mar 15, 2022
SC 13D/A Report SCHEDULE 13D/A, AMENDMENT #7 Feb 22, 2022
SC 13D/A Report SCHEDULE 13D/A, #6 Feb 2, 2022
SC 13D/A Report AMENDED SC13D Jan 18, 2022
SC 13D/A Report SCHEDULE 13D/A, AMENDMENT #5 Jun 14, 2021
SC 13D/A Report SCHEDULE 13D (AMENDMENT NO. 4) May 3, 2021
SC 13D/A Report AMENDMENT TO FORM SC 13D Mar 4, 2021
SC 13D/A Report SCHEDULE 13D/A (AMENDMENT NO. 3) Sep 1, 2020
SC 13D/A Report SCHEDULE 13D/A (AMENDMENT NO. 2) Aug 31, 2020
SC 13D/A Report AMENDMENT NO. 3 TO SCHEDULE 13D Jul 9, 2020
SC 13D/A Report SC 13D/A Jun 18, 2020
SC 13D/A Report SCHEDULE 13D/A (AMENDMENT NO. 1) Jun 12, 2020
SC 13D/A Report AMENDMENT NO. 2 TO SCHEDULE 13D May 1, 2020
SC 13D Report SCHEDULE 13D Apr 23, 2020
SC 13D/A Report AMENDMENT NO. 2 TO SCHEDULE 13D Mar 23, 2020
SC 13D/A Report SC 13D/A Jan 13, 2020
SC 13D/A Report AMENDMENT NO. 1 TO SCHEDULE 13D Jan 11, 2019
SC 13D Report SCHEDULE 13D Dec 24, 2018
SC 13D/A Report SC 13D/A Oct 12, 2018
SC 13D Report SC 13D Oct 10, 2018
SC 13D Report Oct 9, 2018
SC 13D Report CLARUS LIFESCIENCES III, L.P. ENTASIS THERAPEUTICS HOLDINGS INC. -- SCHEDULE 13D Oct 9, 2018
SC 13D Report SC 13D Oct 9, 2018
SC 13D Report SC 13D Oct 5, 2018